TDOC 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

03
价格 $5.52
市值 (MRQ) $1.00B
P/E (TTM) -5.6
EPS (TTM) $-0.99
收入 (TTM) $2.49B
ROE (TTM) -13.0%
52周区间 $4–$10

TDOC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

04
区间
条形图

柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。

关于 Teladoc Health, Inc. Common Stock 公司概况(来自维基百科)

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

行业板块Health Care 行业Health Care 员工4648 国家US

10年表现 收入、净利润、利润率和每股收益趋势

06
收入$2.53B
2016-12-31 → 2025-12-31
EPS$-1.14
2019-12-31 → 2025-12-31
自由现金流$285M
2017-12-31 → 2025-12-31
净利率-7.1%
2017-12-31 → 2025-12-31
估值与比率 07–12

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标 5年趋势 TDOC 5年均值 同行中位数 结论
P/E (TTM) -5.65年均值 ≈-11.5 ≈-11.5 · ·
P/S (TTM) 0.45年均值 ≈2.3 ≈2.3 2.5 低估
市净率 (MRQ) 0.85年均值 ≈1.2 ≈1.2 2.9 低估
股价/自由现金流 (TTM) 4.05年均值 ≈24.5 ≈24.5 · ·
市现率 (TTM) 3.85年均值 ≈23.2 ≈23.2 12.7 低估
市净率(有形资产) (MRQ) 7.5 · · ·

同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。

价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

14
平均惊喜 0.53%
下次报告 十月 27, 2026
期间报告EPS ActualEPS 预期惊喜
2026年6月30日 七月 27, 2026 $-0.21 $-0.25 17.6%
2026年3月31日 $-0.36 $-0.32 -12.6%
2025年12月31日 $-0.14 $-0.19 26.9%
2025年9月30日 $-0.28 $-0.27 -3.2%
2025年6月30日 $-0.19 $-0.27 28.7%
2025年3月31日 $-0.53 $-0.34 -54.2%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

15
损益表 18
指标 趋势 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
资产负债表 28
指标 趋势 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
现金流 18
指标 趋势 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
盈利能力 8
指标 趋势 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
流动性与偿付能力 5
指标 趋势 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
效率 3
指标 趋势 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
每股 5
指标 趋势 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
增长率 3
指标 趋势 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
估值 (TTM) 13
指标 趋势 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

最近期在左侧 · 空值显示为 ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

16
指标 2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $2.53B $2.57B $2.60B $2.41B $2.03B
营业利润率 % -10.4% -39.7% -9.6% -567.3% -13.1%
净收入 $-200M $-1.00B $-220M $-13.66B $-429M
稀释后每股收益 (EPS) $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

机构持有人 (13F) 392 家申报者 · $1.5B 总计 · 截至 2026年9月30日

17

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

持有人 392
持有价值 $1.5B
新仓位 65
已退出持仓 34
机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
65 (-2 与上一季度对比) 34 (-38 与上一季度对比) 111 (-8 与上一季度对比) 94 (+9 与上一季度对比) +11.8M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
VANGUARD GROUP INC $150385949 21483707 9.91% 股份
BlackRock, Inc. $137572176 16223134 9.07% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $107573820 12685592 7.09% 股份
Point72 Asset Management, L.P. $69874581 8239927 4.61% 股份
RENAISSANCE TECHNOLOGIES LLC $68457700 8072842 4.51% 股份
Voss Capital, LP $68235838 8046679 4.50% 股份
VANGUARD CAPITAL MANAGEMENT LLC $67458671 7955032 4.45% 股份
DIMENSIONAL FUND ADVISORS LP $62515646 7371699 4.12% 股份
STATE STREET CORP $42080999 4962382 2.77% 股份
AMERICAN CENTURY COMPANIES INC $41505394 4894504 2.74% 股份
Allianz Asset Management GmbH $39572734 4666596 2.61% 股份
GEODE CAPITAL MANAGEMENT, LLC $39472353 4653834 2.60% 股份
GOLDMAN SACHS GROUP INC $32412969 3822284 2.14% 股份
Monaco Asset Management SAM $26864462 3167979 1.77% 股份
JUPITER ASSET MANAGEMENT LTD $26370375 3109714 1.74% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25976377 3063252 1.71% 股份
Quantinno Capital Management LP $23904416 2818917 1.58% 股份
FEDERATED HERMES, INC. $18037027 2127008 1.19% 股份
UBS Group AG $17401181 2052026 1.15% 股份
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17299632 2040051 1.14% 股份
AMERIPRISE FINANCIAL INC $16998584 2004550 1.12% 股份
Pale Fire Capital SE $16737502 1973762 1.10% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16435088 1938100 1.08% 买入期权
NORTHERN TRUST CORP $15055374 1775398 0.99% 股份
AQR CAPITAL MANAGEMENT LLC $14855924 1751878 0.98% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11710032 1380900 0.77% 卖出期权
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11348708 1338291 0.75% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11229479 1324231 0.74% 股份
MORGAN STANLEY $11055129 1303670 0.73% 股份
VANGUARD FIDUCIARY TRUST CO $10120074 1193405 0.67% 股份
BNP PARIBAS FINANCIAL MARKETS $9796800 1155283 0.65% 股份
FRANKLIN RESOURCES INC $9710439 1145099 0.64% 股份
Allspring Global Investments Holdings, LLC $9024853 991742 0.59% 股份
Freestone Grove Partners LP $7338160 865349 0.48% 股份
Man Group plc $6880545 811385 0.45% 股份
PRINCIPAL FINANCIAL GROUP INC $6827859 805172 0.45% 股份
CITADEL ADVISORS LLC $6795024 801300 0.45% 卖出期权
Union Square Park Capital Management, LLC $6784000 800000 0.45% 股份
CITADEL ADVISORS LLC $6532093 770294 0.43% 股份
FMR LLC $6449076 760504 0.43% 股份
TCW GROUP INC $6248039 736797 0.41% 股份
Voss Capital, LP $5936000 700000 0.39% 买入期权
Empowered Funds, LLC $5764619 679790 0.38% 股份
Bank of New York Mellon Corp $5535043 652717 0.36% 股份
D. E. Shaw & Co., Inc. $5420493 639209 0.36% 股份
PEAK6 LLC $5227920 616500 0.34% 买入期权
CITADEL ADVISORS LLC $5114288 603100 0.34% 买入期权
Squarepoint Ops LLC $5089696 600200 0.34% 买入期权
JANE STREET GROUP, LLC $5088848 600100 0.34% 卖出期权
JPMORGAN CHASE & CO $4283818 484856 0.28% 股份

显示全部 392 个机构持有人 →

激进投资者及 5%+ 股东 2 持仓

18

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Kinnevik AB (publ), Invik S.A. ×3 申报 2021年4月15日 · 初始申报 · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 申报 2021年3月16日 · 初始申报 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

公司内部人士 56 位内幕人士 · 29 位高管 · 24 位董事

19
内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Charles Divita III CHIEF EXECUTIVE OFFICER 2026年9月10日 M 465535 0 7 $-1035229
Laizer Kornwasser Advisor to the CEO 2024年8月1日 M 99929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER 2024年3月19日 A 653073 0 0 $0
Michael F Grasher Chief Financial Officer 2026年9月1日 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER 2025年8月29日 M 142385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 2018年12月13日 M 10000 0 0 $0
Carlos Nueno President, International 2026年9月1日 M 64744 0 4 $-218769
Fernando M. Rodrigues President of BetterHelp 2026年9月1日 M 0 0 8 $-469637
Kelly Bliss President, U.S. Group Health 2026年9月1日 M 92832 0 7 $-343192
Peter A Mcclennen President 2019年7月15日 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER 2024年8月30日 M 78309 0 0 $0
David William Sides Chief Operating Officer 2021年7月29日 M 11031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 2026年9月1日 M 12865 0 7 $-48940
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 2026年9月1日 M 117616 0 4 $-289541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER 2024年9月4日 S 33665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT 2024年9月4日 S 20773 0 0 $0
James L. Cave INTERIM CAO 2024年8月30日 M 13808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer 2024年8月30日 M 75410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER 2024年8月30日 M 44914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER 2024年8月30日 M 31465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER 2024年8月30日 M 48843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER 2024年3月19日 A 18077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER 2023年12月1日 M 20703 0 0 $0
Lewis Levy Chief Medical Officer 2020年10月1日 M 8766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 2020年9月1日 M 3232 0 0 $0
Christopher Caridi Chief Accounting Officer 2020年7月1日 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 2020年4月16日 M 988 0 0 $0
Michael H. King Chief Sales Officer 2017年5月25日 A 61459 0 0 $0
Peter N. Nieves EVP and CRO 2017年3月13日 A · 0 0 $0
Mark V Anquillare 董事 2026年8月3日 A · 0 0 $0
Catherine Jacobson 董事 2026年5月21日 A 66853 0 0 $0
Mark Douglas Smith 董事 2026年5月21日 A 8355 0 0 $0
Kenneth H Paulus 董事 2026年5月21日 A 10000 1 0 $69400
David B Snow JR 董事 2026年5月21日 A 113032 0 0 $0
David L Shedlarz 董事 2026年5月21日 A 61266 0 0 $0
Susan R Salka 董事 2026年3月30日 A · 0 0 $0
Michael S Smith 董事 2026年2月18日 A · 0 0 $0
Jason Eric Evans 董事 2025年12月19日 M 9145 0 0 $0
Thomas Mckinley 董事 2025年5月22日 A 56544 0 0 $0
Karen L Daniel 董事 2024年5月22日 M 36995 0 0 $0
William H. Frist 董事 2022年5月26日 A 12918 0 0 $0
Christopher Bischoff 董事 2022年5月17日 M 7195 0 0 $0
Hemant Taneja 董事 2021年4月19日 S 118760 0 0 $0
Glen Tullman 董事 2021年4月1日 M 275793 0 0 $0
Helen Darling 董事 2020年6月11日 M 918 0 0 $0
Arneek Multani 董事 2019年5月30日 A 918 0 0 $0
Brian P Mcandrews 董事 2019年5月30日 A 1965 0 0 $0
Tom Mawhinney 董事 2018年5月25日 M 46203 0 0 $0
Martin R Felsenthal 董事 2016年8月8日 A 10860 0 0 $0
Dana G Mead Jr. 董事 2016年8月8日 A 202 0 0 $0
James K Outland 董事 2015年7月13日 M 49986 0 0 $0
CHP III Management, L.L.C. 10% 所有者 2017年4月26日 J 2480468 0 0 $0
CHP III LP 10% 所有者 2017年4月26日 J 2480468 0 0 $0
Sandra L Fenwick · 2026年5月21日 A 12070 0 0 $0
Yulun Wang · 2021年1月25日 S 219507 0 0 $0
Michael Goldstein · 2020年6月11日 M 0 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

ETF持仓 由 37 只交易所交易基金持有

20

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
IHF · iShares Trust 0.16% 347966 SH 2026年9月11日 每日
VTWV · VANGUARD SCOTTSDALE FUNDS 0.10% 159976 SH 2026年8月19日 每日
DFSV · Dimensional ETF Trust 0.08% 1038485 NS 2026年7月31日 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.05% 1047849 SH 2026年8月19日 每日
ESML · iShares Trust 0.05% 219811 SH 2026年9月11日 每日
BBSC · J.P. Morgan Exchange-Traded Fund ... 0.05% 47383 NS 2026年7月31日 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.04% 29737 SH 2026年8月19日 每日
RSSL · Global X Funds 0.04% 87202 NS 2026年7月31日 N-PORT
IWM · iShares Trust 0.04% 4676471 SH 2026年9月11日 每日
VBR · VANGUARD INDEX FUNDS 0.03% 2631374 SH 2026年8月19日 每日
PNQI · Invesco Exchange-Traded Fund Trust 0.03% 27091 SH 2026年10月1日 每日
DFAT · Dimensional ETF Trust 0.02% 528876 NS 2026年7月31日 N-PORT
VXF · VANGUARD INDEX FUNDS 0.02% 2084219 SH 2026年8月19日 每日
VB · VANGUARD INDEX FUNDS 0.02% 4153113 SH 2026年8月19日 每日
VHT · VANGUARD WORLD FUND 0.02% 535056 SH 2026年8月19日 每日
FHLC · FIDELITY COVINGTON TRUST 0.02% 83458 NS 2026年7月31日 N-PORT
DFAS · Dimensional ETF Trust 0.01% 325784 NS 2026年7月31日 N-PORT
DXUV · Dimensional ETF Trust 0.01% 11242 NS 2026年7月31日 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.01% 176576 SH 2026年10月1日 每日
WSML · iShares Trust 0.01% 10496 SH 2026年9月11日 每日
TILT · FlexShares Trust 0.01% 21330 NS 2026年7月31日 N-PORT
DFAC · Dimensional ETF Trust 0.01% 449072 NS 2026年7月31日 N-PORT
DFSU · Dimensional ETF Trust 0.01% 18459 NS 2026年7月31日 N-PORT
DCOR · Dimensional ETF Trust 0.00% 23195 NS 2026年7月31日 N-PORT
DSI · iShares Trust 0.00% 25114 SH 2026年9月10日 每日
DFUS · Dimensional ETF Trust 0.00% 82328 NS 2026年7月31日 N-PORT
DFAU · Dimensional ETF Trust 0.00% 43186 NS 2026年7月31日 N-PORT
ITOT · iShares Trust 0.00% 232868 SH 2026年9月11日 每日
IWV · iShares Trust 0.00% 45761 SH 2026年9月3日 每日
DFUV · Dimensional ETF Trust 0.00% 16298 NS 2026年7月31日 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 5687282 SH 2026年8月19日 每日
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 15175 SH 2026年8月19日 每日
IWN · iShares Trust · 1697159 SH 2026年9月11日 每日
SVAL · iShares Trust · 100159 SH 2026年9月3日 每日
ISCB · iShares Trust · 7717 SH 2026年9月11日 每日
ISCV · iShares Trust · 38629 SH 2026年9月11日 每日
SMLF · iShares Trust · 597716 SH 2026年9月11日 每日

TDOC 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

21
评级 · 31 位分析师 持有
中位数目标 $7.50 +35.9%
4 12.9% 强烈买入
7 22.6% 买入
20 64.5% 持有
0 0.0% 卖出
0 0.0% 强烈卖出

12个月价格目标

17 位分析师 · 2026-10-02

平均目标 $7.68 +39.1%

现在 当前价格 $5.52
最低$5.50 平均值$7.68 最高$10.50

同行比较(GICS 子行业) 关键指标与行业同行对比

22

财年依据,价格截至各公司上一个财年末收盘价。

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

最新新闻 提及该公司的近期头条新闻

23

我的指标 您的个人关注列表 — 来自完整基本面的选定行

26

选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。

您的选择已保存,并会跟随您浏览所有股票。

来源:SEC 10-Q 于 七月 30, 2026 申报